An atypical role for the myeloid receptor Mincle in central nervous system injury

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 6, 2017, Pages 2098-2111

  Arumugam, Thiruma V ^a,b   Manzanero, Silvia ^b   Furtado, Milena ^c,d   Biggins, Patrick J ^b   Hsieh, Yu Hsuan ^a   Gelderblom, Mathias ^e   MacDonald, Kelli PA ^f   Salimova, Ekaterina ^c   Li, Yu I ^g   Korn, Othmar ^b   Dewar, Deborah ^h   Macrae, I Mhairi ^h   Ashman, Robert B ^b   Tang, Sung Chun ^g   Rosenthal, Nadia A ^c,d   Ruitenberg, Marc J ^b   Magnus, Tim ^e   Wells, Christine A ^b,i  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d JACKSON LABORATORY   (United States)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^h UNIVERSITY OF GLASGOW   (United Kingdom)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

C type lectin; Ischemia; Microglia; Middle cerebral artery occlusion; Sterile inflammation

Indexed keywords

LECTIN; MYELOPEROXIDASE; OXYGEN; CLECSF8 PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FLOW CYTOMETRY; HEART INFARCTION; HISTOLOGY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INNATE IMMUNITY; INTESTINE ISCHEMIA; MALE; MICROARRAY ANALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL CULTURE; NERVOUS SYSTEM INJURY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; TISSUE INJURY; TUNEL ASSAY; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INTESTINE; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION INJURY; VASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HYPOXIA-ISCHEMIA, BRAIN; IN SITU NICK-END LABELING; INTESTINES; LECTINS, C-TYPE; MALE; MEMBRANE PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MYOCARDIAL INFARCTION; REPERFUSION INJURY; SPINAL CORD INJURIES;

EID: 85019766214     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16661201     Document Type: Article

References (47)

1. Woodruff TM, et al. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener 2011; 6: 11.
2. Chamorro A, et al. The immunology of acute stroke. Nat Rev Neurol 2012; 8: 401–410.
3. Murray KN, Buggey HF, Denes A, et al. Systemic immune activation shapes stroke outcome. Mol Cell Neurosci 2013; 53: 14–25.
4. Tang SC, et al. Pivotal role for neuronal toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 2007; 104: 13798–13803.
5. Heiman A, Pallottie A, Heary RF, et al. Toll-like receptors in central nervous system injury and disease: a focus on the spinal cord. Brain Behav Immun 2014; 42: 232–245.
6. Downes CE, et al. MyD88 Is a critical regulator of hematopoietic cell-mediated neuroprotection seen after stroke. PLoS One 2013; 8: e57948.
7. Vartanian KB, et al. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J Neuroinflammation 2011; 8: 140.
8. Kim D, et al. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 2007; 282: 14975–14983.
9. Kigerl KA, et al. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem 2007; 102: 37–50.
10. Brea D, et al. Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values. J Cereb Blood Flow Metab 2011; 31: 1424–1431.
11. Maestrini I, et al. Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes. Neurol 2015; 85: 1408–1416.
12. Holloway PM, et al. Both MC1 and MC3 receptors provide protection from cerebral ischemia-reperfusion-induced neutrophil recruitment. Arterioscler Thromb Vasc Biol 2015; 35: 1936–1944.
13. Mori E, del Zoppo GJ, Chambers JD, et al. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 1992; 23: 712–718.
14. Neumann J, et al. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke. Acta Neuropathol 2015; 129: 259–277.
15. Lalancette-Hébert M, Gowing G, Simard A, et al. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007; 27: 2596–2605.
16. Russo MV, McGavern DB. Immune surveillance of the CNS following infection and injury. Trends Immunol 2015; 36: 637–650.
17. Yamasaki S, et al. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol 2008; 9: 1179–1188.
18. Matsumoto M, et al. A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages. J Immunol 1999; 163: 5039–5048.
19. Schoenen H, et al. Cutting edge: mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol 2010; 184: 2756–2760.
20. Vijayan D, Radford KJ, Beckhouse AG, et al. Mincle polarizes human monocyte and neutrophil responses to Candida albicans. Immunol Cell Biol 2012; 90: 889–895.
21. Wells CA, et al. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J Immunol 2008; 180: 7404–7413.
22. Drummond RA, Saijo S, Iwakura Y, et al. The role of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur J Immunol 2011; 41: 276–281.
23. Strasser D, et al. Syk kinase-coupled C-type lectin receptors engage protein kinase C-sigma to elicit Card9 adaptor-mediated innate immunity. Immunity 2012; 36: 32–42.
24. Andre P, et al. Critical role for Syk in responses to vascular injury. Blood 2011; 118: 5000–5010.
25. He Y, et al. Macrophage-inducible C-type lectin/spleen tyrosine kinase signaling pathway contributes to neuroinflammation after subarachnoid hemorrhage in rats. Stroke 2015; 46: 2277–2286.
26. Suzuki Y, et al. Involvement of Mincle and Syk in the changes to innate immunity after ischemic stroke. Sci Rep 2013; 3: 3177.
27. Ishikawa E, et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 2009; 206: 2879–2888.
28. Bederson JB, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986; 17: 472–476.
29. Gelderblom M, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009; 40: 1849–1857.
30. Harrison M, et al. Vertebral landmarks for the identification of spinal cord segments in the mouse. Neuroimage 2013; 68: 22–29.
31. Blomster LV, et al. Mobilisation of the splenic monocyte reservoir and peripheral CX3CR1 deficiency adversely affects recovery from spinal cord injury. Exp Neurol 2013; 247: 226–240.
32. Brennan FH, et al. The complement receptor C5aR controls acute inflammation and astrogliosis following spinal cord injury. J Neurosci 2015; 35: 6517–6531.
33. Basso DM, et al. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 2006; 23: 635–659.
34. Pamuk ON, et al. Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2010; 299: G391–G399.
35. Wells CA, et al. Stemformatics: visualisation and sharing of stem cell gene expression. Stem Cell Res 2012; 10: 387–395.
36. Smyth GK. Limma: Linear models for microarray data. In: Gentleman R, Carey V, Huber W, et al. (eds) Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer, 2005, pp.397–420
37. Tarr D, et al. Hyperglycemia accelerates apparent diffusion coefficient-defined lesion growth after focal cerebral ischemia in rats with and without features of metabolic syndrome. J Cereb Blood Flow Metab 2013; 33: 1556–1563.
38. de Rivero Vaccari JC, et al. Mincle signaling in the innate immune response after traumatic brain injury. J Neurotrauma 2014; 236: 228–236.
39. Gomez Perdiguero E, Schulz C, Geissmann F. Development and homeostasis of ‘resident’ myeloid cells: the case of the microglia. Glia 2013; 61: 112–120.
40. Kim W-K, et al. CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am J Pathol 2006; 168: 822–834.
41. Shi X. Resident macrophages in the cochlear blood-labyrinth barrier and their renewal via migration of bone-marrow-derived cells. Cell Tissue Res 2010; 342: 21–30.
42. Zhang W, et al. Perivascular-resident macrophage-like melanocytes in the inner ear are essential for the integrity of the intrastrial fluid-blood barrier. Proc Natl Acad Sci U S A 2012; 109: 10388–10393.
43. Shichita T, et al. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med 2012; 18: 911–917.
44. Bartanusz V, Jezova D, Alajajian B, et al. The blood-spinal cord barrier: Morphology and clinical implications. Ann Neurol 2011; 70: 194–206.
45. Hall CN, et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature 2014; 508: 55–60.
46. Fernandez-Klett F, Priller J. Diverse functions of pericytes in cerebral blood flow regulation and ischemia. J Cereb Blood Flow Metab 2015; 35: 883–887.
47. Proebstl D, et al. Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J Exp Med 2012; 209: 1219–1234.